UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000006877
Receipt No. R000008105
Scientific Title Phase II study of XELIRI with bevacizumab as second-line therapy for metastatic colorectal cancer -Beyond Progression Disease of capecitabine and bebacizumab -
Date of disclosure of the study information 2011/12/12
Last modified on 2020/07/28 11:20:42

No. Disposal Last modified on Item of update
1 Insert 2011/12/12 14:50:02
2 Update 2013/12/12 14:42:44 TEL
Email
Email
3 Update 2014/06/13 14:33:58 Email
Email
4 Update 2015/08/12 14:37:26 Recruitment status
5 Update 2020/07/28 11:20:42 Recruitment status
Date of IRB
Last follow-up date


Contact us.